Key Statistics
Market Cap$473.50M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.89
52W High$11.61
52W Low$1.34
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees21
Price Performance
1 Week+9.69%
3 Month+75.29%
1 Year+465.82%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$19.93M
Liabilities$3.72M
Net Income$15.60M loss
About
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology and inflammation in the United States and Australia. The company is headquartered in Los Angeles, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze IMMX with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.